Profil PT Anvita Pharma Indonesia

Profil Perusahaan / Lembaga - PT. Anvita Pharma Indonesia
Deskripsi Perusahaan / Kelembagaan

PT Anvita Pharma Indonesia is a research driven pharmaceutical company that aims to be at the forefront as a developer and producer of high quality active pharmaceutical ingredients for the needs of the Indonesian pharmaceutical industry and for export to ASEAN markets. Anvita Pharma has successfully developed technologies that reduce the risks, timelines and costs in drug development for life-saving drugs. These technologies are incorporated into our state-of-art API manufacturing plant, built on 25,000 sqm of land within KNIC, a world-class integrated industrial estate close to Jakarta in Indonesia.

PT Anvita Pharma Indonesia, formerly known as PT BrightGene Biomedical Indonesia, is dedicated to advancing the pharmaceutical landscape in Indonesia and Southeast Asia. Established in 2018, we proudly stand as Indonesia’s first privately owned Active Pharmaceutical Ingredient (API) company focused on small molecules. With our state-of-the-art GMP-certified facility we are committed to bridging the gap in local API production and supporting national resilience in healthcare.

The name “Anvita” is derived from Sanskrit and means “the one who bridges the gap,” symbolizing knowledge, understanding, and wisdom. Anvita embodies our mission to bridge production gaps in APIs and finished products within Indonesia, collaborating with partners across the region to enhance local capabilities and self-sufficiency.

MISSION
To become a leading API provider in ASEAN, addressing unmet medical needs with advanced technologies and producing high-quality, reliable pharmaceutical products that improve the lives of patients and their families.  

Your Partner in Pharmaceutical Excellence
As a Contract Development and Manufacturing Organization (CDMO), Anvita specializes in small molecule API production, offering end-to-end services tailored to meet the needs of our partners with a strong focus on quality and reliability. We are dedicated to supporting local and international pharmaceutical companies in bringing high-quality, affordable medicines to market.